-
EP2531177
European procedure
Extract from the Register of European Patents
EP About this file: EP2531177
| EP2531177 - 4-[2-[[5-METHYL-1-(2-NAPHTHALENYL)-1H-PYRAZOL-3-YL]OXY]ETHYL]MORPHOLINE HYDROCHLORIDE POLYMORPHS AND SOLVATES [Right-click to bookmark this link] | |||
| Former [2012/50] | 4-[-2-[[5-METHYL-1-(2-NAPHTALENYL)-1H-PYRAZOL-3-YL]OXY]ETHYL]MORPHOLINE HYDROCHLORIDE POLYMORPHS AND SOLVATES | ||
| [2015/45] | Status | No opposition filed within time limit Status updated on 17.03.2017 Database last updated on 30.10.2024 | Most recent event Tooltip | 17.03.2017 | No opposition filed within time limit | published on 19.04.2017 [2017/16] | Applicant(s) | For all designated states Laboratorios del Dr. Esteve, S.A. Avda Mare de Deu de Montserrat 221 08041 Barcelona / ES | [2016/19] |
| Former [2012/50] | For all designated states Laboratorios del. Dr. Esteve, S.A. Avda Mare de Deu de Montserrat 221 08041 Barcelona / ES | Inventor(s) | 01 /
BERENGUER MAIMÓ, Ramón Jovellanos 1 Izda. 4º 3ª E-08001 Barcelona / ES | 02 /
MEDRANO RUPÉREZ, Jorge C/Rosari 18, átic 2a E-08921 Santa Colonia de Gramenet Barcelona / ES | 03 /
BENET BUCHHOLZ, Jordi Plaza Romani 3 - Casa A E-43893 Altafulla - Tarragona / ES | 04 /
PUIG FERNANDEZ, Laura El Maquinista de la General 37 - 2A E-50019 Zaragoza / ES | 05 /
PELLEJÀ PUXEU, Laia Cigne 17 - Casa 6 E-43007 Tarragona / ES | [2016/19] |
| Former [2012/50] | 01 /
BERENGUER MAIMÓ, Ramón Jovellanos 1 Izda. 4º 3ª E-08001 Barcelona / ES | ||
| 02 /
MEDRANO RUPÉREZ, Jorge C/Rosari 18, atic 2a E-08921 Santa Colonia de Gramenet Barcelona / ES | |||
| 03 /
BENET BUCHHOLZ, Jordi Plaza Romani 3 - Casa A E-43893 Altafulla - Tarragona / ES | |||
| 04 /
PUIG FERNANDEZ, Laura El Maquinista de la General 37 - 2A E-50019 Zaragoza / ES | |||
| 05 /
PELLEJÀ PUXEU, Laia Cigne 17 - Casa 6 E-43007 Tarragona / ES | Representative(s) | ABG Intellectual Property Law, S.L. Avenida de Burgos, 16D Edificio Euromor 28036 Madrid / ES | [N/P] |
| Former [2012/50] | ABG Patentes, S.L. Avenida de Burgos, 16D Edificio Euromor 28036 Madrid / ES | Application number, filing date | 11702056.0 | 04.02.2011 | [2016/19] | WO2011EP51630 | Priority number, date | EP20100382226 | 09.08.2010 Original published format: EP 10382226 | EP20100382025 | 04.02.2010 Original published format: EP 10382025 | [2012/50] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2011095579 | Date: | 11.08.2011 | Language: | EN | [2011/32] | Type: | A1 Application with search report | No.: | EP2531177 | Date: | 12.12.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 11.08.2011 takes the place of the publication of the European patent application. | [2012/50] | Type: | B1 Patent specification | No.: | EP2531177 | Date: | 11.05.2016 | Language: | EN | [2016/19] | Type: | B8 Corrected title page of specification | No.: | EP2531177 | Date: | 12.10.2016 | [2016/41] | Search report(s) | International search report - published on: | EP | 11.08.2011 | Classification | IPC: | A61K9/16, A61K31/4152, C07D231/22, A61P25/00 | [2012/50] | CPC: |
C07D231/22 (EP,KR,US);
C07D413/12 (KR);
A61K31/4152 (EP,KR,US);
A61K31/4155 (EP,US);
A61P25/00 (EP);
A61P25/04 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2012/50] | Extension states | BA | 30.08.2012 | ME | 30.08.2012 | Title | German: | 4-[2-[[5-METHYL-1-(2-NAPHTHALINYL)-1H-PYRAZOL-3-YL]OXY]ETHYL]MORPHOLIN HYDROCHLORID POLYMORPHE UND SOLVATE | [2016/21] | English: | 4-[2-[[5-METHYL-1-(2-NAPHTHALENYL)-1H-PYRAZOL-3-YL]OXY]ETHYL]MORPHOLINE HYDROCHLORIDE POLYMORPHS AND SOLVATES | [2016/21] | French: | POLYMORPHES D'UN SEL DE CHLORHYDRATE DE 4-[2-[[5-METHYL-1-(2-NAPHTHALENYL)-1H-PYRAZOL-3-YL]OXY]ETHYL]MORPHOLINE ET DES SOLVATES | [2016/21] |
| Former [2012/50] | 4-[-2-[[5-METHYL-1-(2-NAPHTHALENYL)-1H-PYRAZOL-3-YL]OXY]ETHYL]MORPHOLINHYDROCHLORIDPOLYMORPHE UND -SOLVATE | ||
| Former [2012/50] | 4-[-2-[[5-METHYL-1-(2-NAPHTALENYL)-1H-PYRAZOL-3-YL]OXY]ETHYL]MORPHOLINE HYDROCHLORIDE POLYMORPHS AND SOLVATES | ||
| Former [2012/50] | POLYMORPHES ET SOLVATES DE CHLORHYDRATE DE 4-[-2-[[5-MÉTHYL-1-(2-NAPHTALÉNYL)-1H-PYRAZOL-3-YL]OXY]ÉTHYL]MORPHOLINE | Entry into regional phase | 30.08.2012 | National basic fee paid | 30.08.2012 | Designation fee(s) paid | 30.08.2012 | Examination fee paid | Examination procedure | 30.08.2012 | Amendment by applicant (claims and/or description) | 30.08.2012 | Examination requested [2012/50] | 18.11.2013 | Despatch of a communication from the examining division (Time limit: M04) | 27.03.2014 | Reply to a communication from the examining division | 29.09.2015 | Cancellation of oral proceeding that was planned for 11.11.2015 | 20.10.2015 | Communication of intention to grant the patent | 11.11.2015 | Date of oral proceedings (cancelled) | 15.02.2016 | Fee for grant paid | 15.02.2016 | Fee for publishing/printing paid | 15.02.2016 | Receipt of the translation of the claim(s) | 11.04.2016 | Request for correction of the decision to grant filed | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 18.11.2013 | Opposition(s) | 14.02.2017 | No opposition filed within time limit [2017/16] | Fees paid | Renewal fee | 08.02.2013 | Renewal fee patent year 03 | 21.01.2014 | Renewal fee patent year 04 | 16.01.2015 | Renewal fee patent year 05 | 11.01.2016 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [ID]WO2006021462 (ESTEVE LABOR DR [ES], et al) [ID] 1-18 * page 15 - page 16; example 61; claim 10 *; | [I]EP2113501 (ESTEVE LABOR DR [ES]) [I] 1-18 * paragraph [0034]; claim 1 *; | [A] - LEE S ET AL, Handbook of Pharmaceutical Salts: Properties, Selection , and Use, Chapter 8 (Large-Scale Aspects of Salt Formation: Processing of Intermediates and Final Products, Chapter 12 (Monographs on Acids and Bases), HANDBOOK OF PHARMACEUTICAL SALTS : PROPERTIES, SELECTION, AND USE, ZÜRICH : VERL. HELVETICA CHIMICA ACTA ; WEINHEIM [U.A.] : WILEY-VCH, DE, PAGE(S) 191 - 192,211, (20020101), ISBN 978-3-906390-26-0, XP002548973 [A] 1-18 * page 192 * * page 211 - page 213 * | [A] - BERGE S M ET AL, "PHARMACEUTICAL SALTS", JOURNAL OF PHARMACEUTICAL SCIENCES, AMERICAN PHARMACEUTICAL ASSOCIATION, WASHINGTON, US, (19770101), vol. 66, no. 1, doi:DOI:10.1002/JPS.2600660104, ISSN 0022-3549, pages 1 - 19, XP002552191 [A] 1-18 * page 7, column r * * page 1, column r; table 1 * DOI: http://dx.doi.org/10.1002/jps.2600660104 | by applicant | WO2006021462 | - WALKER, J.M. ET AL., PHARMACOLOGICAL REVIEWS, (1990), vol. 42, page 355 | - SNYDER, S.H., LARGENT, B.L. J. NEUROPSYCHIATRY, (1989), vol. 1, page 7 | - QUIRION, R. ET AL., TRENDS PHARMACOL. SCI., (1992), vol. 13, pages 85 - 86 | - HANNER, M. ET AL., PROC. NATL. ACAD. SCI., (1996), vol. 93, pages 8072 - 8077 | - M. LANG ET AL., J. AM. CHEM. SOC., (2002), vol. 124, page 14834 | - C. PRICE ET AL., J. AM. CHEM. SOC., (2005), vol. 127, page 5512 |